Shkreli is accused of ripping off his former pharma company Retrophin to pay off hedge-fund investors he was accused of defrauding. » Read More
By: Rachel Cao
Shares of Bristol-Myers climbed as much as 4 percent after billionaire Carl Icahn reportedly took a stake in the company, according to Dow Jones. » Read More
Momenta says Pfizer, a key supplier for its multiple sclerosis drug, has received a warning letter from the Food and Drug Administration. » Read More
By: Trent Gillies
Former Aetna CEO Ron Williams weighs in on what changes could be ahead for the Affordable Care Act and consumers. » Read More
UnitedHealth denies allegations it gamed the nation's Medicare system for hundreds of millions of dollars.
The burdens of repealing and replacing Obamacare will fall on consumers, Mark Cuban tells CNBC.
House Speaker Paul Ryan said they plan to introduce legislation as early as next Tuesday.
Spending on health nationally grew by an estimated 4.8 percent in 2016, but is expected to rise at a quicker pace through 2025.
This is occurring even as the Trump administration issues new rules to try to stabilize the Obamacare exchanges.
Tax filers remain responsible for paying a penalty if they fail to have health insurance coverage or an exemption from that mandate.
Researchers used brain scans and an algorithm to improve early diagnosis of autism among several high-risk children.
Open enrollment would run from November through Dec. 15, and states would have control over the size of an insurance plan's network.
Health sensors are popping up in a new place: directly on the skin. Patch start-ups think they will succeed where Fitbit has struggled.
Dermatologists and other specialists are three times more likely than primary care providers to prescribe brand name versions of drugs known as topical immunomodulators.
The three cases occurred in the past two months in a Bronx neighborhood. City officials say it's the first time a cluster of cases has been identified.
In the wake of Humana's comment, President Donald Trump tweeted that the insurer's decision was another example of Obamacare's failure.
Last week, a federal judge blocked the deal, saying it would lead to higher prices and reduced competition.
Just 8.8 percent of Americans lack health coverage as Republicans move to repeal key parts of the Affordable Care Act.
Health insurer Aetna and rival Humana say they have mutually ended their $34 billion merger agreement.
Marathon says it will charge $89,000 for its Duchenne muscular dystrophy treatment, despite it having sold elsewhere for just $1,000.
Get the best of CNBC in your inbox